Zacks: Analysts Anticipate Teradyne, Inc. (NYSE:TER) Will Announce Quarterly Sales of $744.03 Million

Equities research analysts predict that Teradyne, Inc. (NYSE:TERGet Rating) will post sales of $744.03 million for the current quarter, Zacks Investment Research reports. Four analysts have made estimates for Teradyne’s earnings, with the highest sales estimate coming in at $765.00 million and the lowest estimate coming in at $731.00 million. Teradyne posted sales of $781.61 million during the same quarter last year, which would indicate a negative year over year growth rate of 4.8%. The firm is expected to report its next quarterly earnings report after the market closes on Monday, January 1st.

On average, analysts expect that Teradyne will report full year sales of $3.45 billion for the current fiscal year, with estimates ranging from $3.32 billion to $3.61 billion. For the next year, analysts forecast that the firm will post sales of $4.19 billion, with estimates ranging from $3.89 billion to $4.54 billion. Zacks’ sales calculations are a mean average based on a survey of sell-side research analysts that that provide coverage for Teradyne.

Separately, assumed coverage on shares of Teradyne in a report on Thursday, March 31st. They issued a “hold” rating for the company.

NYSE TER opened at $109.20 on Friday. Teradyne has a 1 year low of $102.51 and a 1 year high of $168.91.

About Teradyne (Get Rating)

Teradyne, Inc designs, develops, manufactures, sells, and supports automatic test equipment worldwide. The company operates through Semiconductor Test, System Test, Industrial Automation, and Wireless Test segments. The Semiconductor Test segment offers products and services for wafer level and device package testing in automotive, industrial, communications, consumer, smartphones, cloud computer and electronic game, and other applications.

Featured Articles

Get a free copy of the Zacks research report on Teradyne (TER)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Teradyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teradyne and related companies with's FREE daily email newsletter.